PL
BSX icon

Plancorp LLC’s Boston Scientific BSX Stock Holding History

Plancorp LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,538
Closed -$219K – 429
2026
Q1 		$219K Buy
3,538
+502
+17% +$40.2K 0.01% 345
2025
Q4 		$289K Buy
3,036
+16
+0.5% +$1.57K 0.01% 296
2025
Q3 		$295K Sell
3,020
-105
-3% -$10.9K 0.01% 300
2025
Q2 		$336K Buy
3,125
+79
+3% +$7.99K 0.01% 280
2025
Q1 		$307K Buy
3,046
+243
+9% +$24.5K 0.01% 276
2024
Q4 		$250K Buy
2,803
+145
+5% +$12.8K 0.01% 275
2024
Q3 		$223K Buy
+2,658
New +$210K 0.01% 288

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Plancorp LLC's BSX Position: Q2 2026 in Review

Plancorp LLC sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,538 shares — an estimated $219K sold.

Plancorp LLC first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $336K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Plancorp LLC reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Plancorp LLC sold 3,538 Boston Scientific shares in Q2 2026, an estimated $219K.
  • Plancorp LLC first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Plancorp LLC's Boston Scientific position peaked at $336K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.